Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 18Rectal Neoplasms 7Colorectal Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 4Neoplasms 3Breast Carcinoma In Situ 3Urinary Bladder Neoplasms 2Sarcoma 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Colonic Neoplasms 2Bites and Stings 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Stress, Psychological 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Seminoma 1Rhabdoid Tumor 1Retinoblastoma 1Prostatic Neoplasms 1Peritoneal Metastases From Gastric Cancer 1Peritoneal Metastases From Colorectal Cancer 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasm, Residual 1Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1Muscle Invasive Bladder Cancer 1Motor Activity 1

Interventions

Zoledronic Acid 1Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Breast Cancer Metastatic × Neoadjuvant Therapy × Clear all
NCT06876636 2025-07-29

Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer

Xijing Hospital

Phase NA Active not recruiting
99 enrolled
Breast

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡